Novartis

Two biotechs target dry eye disease after Novartis’ Xiidra problems
Pharmaforum
Thu, 03/4/21 - 09:57 am
dry eye disease
Novartis
Xiidra
Sylentis
Azura Ophthalmics
Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU
Endpoints
Thu, 03/4/21 - 09:48 am
Novartis
vaccines
CureVac
COVID-19
drug manufacturing
Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease of use
Fierce Pharma
Wed, 03/3/21 - 10:58 am
Novartis
Kesimpta
MS
multiple sclerosis
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales
Fierce Pharma
Mon, 02/22/21 - 10:49 am
Novartis
executive pay
Vas Narasimhan
Pharma CEOs
pandemic
COVID-19
A month after multi-billion dollar Novartis deal, BeiGene follows up with 'reverse' deal
Endpoints
Thu, 02/18/21 - 10:40 am
BieGene
Novartis
Boston Immune Technologies
TNFR2
Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world
Stat
Wed, 02/17/21 - 10:41 am
Novartis
Gates Foundation
gene therapy
sickle cell disease
Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group
Fierce Pharma
Tue, 02/16/21 - 11:40 pm
Novartis
Entresto
heart failure
labeling
FDA
GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout
Fierce Pharma
Fri, 02/12/21 - 11:09 am
GSK
Novartis
Sandoz
layoffs
antibiotics
drug manufacturing
Novartis’s canakinumab cancer test approaches
EP Vantage
Fri, 02/12/21 - 11:06 am
Novartis
Regeneron
canakinumab
cancer
non-small cell lung cancer
Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands
Fierce Pharma
Thu, 02/11/21 - 10:26 pm
Novartis
Sandoz
generics
antibiotics
Novartis' 2021 access goal: solutions as 'innovative as the science itself'
Fierce Pharma
Mon, 02/8/21 - 10:24 pm
Novartis
innovation
Novartis in Talks to Join Pharma Industry’s Covid Vaccine Push
Yahoo/Bloomberg
Thu, 01/28/21 - 10:36 am
Novartis
vaccines
COVID-19
GSK, Novartis, J&J and Pfizer lead pharma at making their meds accessible: report
Fierce Pharma
Tue, 01/26/21 - 11:30 pm
GSK
Novartis
JNJ
Pfizer
accessibility
Novartis' Q4 earnings clouded by regulatory setbacks on inclisiran, Zolgensma
Endpoints
Tue, 01/26/21 - 11:30 am
Novartis
earnings
inclisiran
Zolgensma
Novartis, GSK team up for $3.6m genetic diversity research in Africa
Pharmaceutical Business Review
Wed, 01/20/21 - 10:35 am
Novartis
GSK
genetic diversity
Africa
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
Novartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria
Pharmaceutical Business Review
Fri, 01/15/21 - 09:49 am
Novartis
breakthrough therapy
FDA
ligelizumab
chronic spontaneous urticaria
JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works
Fierce Biotech
Tue, 01/12/21 - 11:04 am
JPMHC 2021
pandemic
Novartis
COVID-19
R&D
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Mon, 01/11/21 - 06:56 pm
Novartis
BeiGene
tiselizumab
cancer
drug development
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical

Pages